Medicine and Dentistry
Congestive Heart Failure
98%
COVID-19
70%
Myocarditis
55%
Acute Decompensated Heart Failure
36%
Cardiovascular System
28%
ST Segment Elevation Myocardial Infarction
28%
Primary Percutaneous Coronary Intervention
27%
Dilated Cardiomyopathy
25%
All Cause Mortality
25%
Cardiology
24%
Cardiac Magnetic Resonance Imaging
23%
Heart Failure with Preserved Ejection Fraction
23%
Stromal Cell Derived Factor 1
23%
Reperfusion Injury
23%
Hospital Mortality
23%
Myocardium
19%
Prevalence
18%
Patient Referral
17%
Biological Marker
16%
Glycon
15%
Cohort Analysis
15%
Progenitor Cell
15%
Cardiac Regeneration
15%
Acute Heart Infarction
15%
Cardiovascular Disease
14%
Heart Failure with Reduced Ejection Fraction
14%
Heart Left Ventricle Ejection Fraction
12%
Infarction
12%
Myocardial Infarction
11%
Myocardial Disease
11%
Electronic Health Record
11%
Chemokine
10%
Language Processing
10%
Stem Cell
10%
Ejection Fraction
9%
Decompensated Heart Failure
9%
Patient with Type 2 Diabetes
9%
Prospective Study
9%
Lymphocyte
9%
Neutrophil
9%
Implantable Automatic Defibrillator
8%
Gadolinium
8%
Adverse Outcome
8%
Pleiotropy
8%
Hazard Ratio
8%
Comorbidity
8%
Cardiac Muscle Cell
7%
Heart Muscle Revascularization
7%
Adipose Tissue
7%
Seminoma
7%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Myocarditis
47%
Pandemic
47%
Congestive Cardiomyopathy
41%
Acute Heart Failure
32%
Cardiovascular Disease
28%
Prevalence
28%
All Cause Mortality
27%
ST Segment Elevation Myocardial Infarction
24%
Stromal Cell Derived Factor 1
23%
Heart Infarction
21%
Beta Adrenergic Receptor Blocking Agent
20%
Cohort Study
19%
Non Insulin Dependent Diabetes Mellitus
18%
Reperfusion Injury
18%
Myocardial Disease
17%
Hospital Mortality
17%
Metformin
16%
Diuretics
15%
Biological Marker
15%
Acute Heart Infarction
15%
Diseases
13%
Infarction
13%
Heart Arrhythmia
12%
Heart Injury
11%
Heart Muscle Injury
10%
Anemia
10%
Heart Failure with Reduced Ejection Fraction
10%
Bleeding
10%
Heart Muscle Ischemia
9%
Clinical Research
9%
Adverse Outcome
9%
Prospective Study
9%
Chemokine
9%
Mortality Rate
9%
Functional Status
8%
Furosemide
7%
Ischemic Cardiomyopathy
7%
Antiarrhythmic Agent
7%
Ammonium Tetrathiomolybdate
7%
Sulfide
7%
Thioether
7%
Antiinfective Agent
7%
Malignant Neoplasm
7%
Connectin
7%
Faintness
7%
Coronavirinae
7%
Cardiotoxicity
7%
Acute Coronary Syndrome
7%
Patient History of Chemotherapy
7%